Moolec Science director reports option holdings

Moolec Science SA director Lorenzo Varela has filed a Form 3 reporting his initial beneficial ownership in the company.

Accepted by SEC EDGAR 03/18/2026 - 06:38 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Moolec Science SA director Lorenzo Varela has filed a Form 3 reporting his initial beneficial ownership in the company. The filing shows three direct option-based positions over ordinary shares, each with a $7.14 exercise price and expirations in 2031, 2032, and 2033.

The underlying options cover 934, 933, and 933 ordinary shares, respectively, and are structured as share options rather than open-market share purchases or sales. The disclosure is administrative, establishing his baseline holdings without reporting any new buy or sell transactions.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Varela Lorenzo Romualdo Mariano

Role Director

Type	Security	Shares	Price	Value
Holding	Ordinary shares	--	--	--
Holding	Ordinary shares	--	--	--
Holding	Ordinary shares	--	--	--

Holdings: Ordinary shares — 2,800 contracts (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Moolec Science (MLEC) Form 3 for Lorenzo Varela report?

The Form 3 reports director Lorenzo Varela’s initial beneficial ownership in Moolec Science. It lists three direct option-based positions over ordinary shares, establishing his baseline holdings without indicating any open-market purchases or sales in this filing.

How many Moolec Science (MLEC) shares are covered by Lorenzo Varela’s options?

The filing shows options over three blocks of ordinary shares: 934, 933, and 933 underlying shares. These amounts are tied to separate share option positions and define the scale of his potential future ownership if the options are exercised.

What is the exercise price of Lorenzo Varela’s Moolec Science (MLEC) share options?

Each reported share option position carries an exercise price of $7.14 per ordinary share. This means Varela can acquire the underlying shares at that fixed price if he chooses to exercise the options before their expiration dates.

When do Lorenzo Varela’s Moolec Science (MLEC) options expire?

The options tied to Moolec Science ordinary shares expire on three different dates: June 30, 2031, June 30, 2032, and June 30, 2033. These staggered expirations define long-term timeframes for potential option exercises.

Does the Moolec Science (MLEC) Form 3 show any insider buying or selling?

The Form 3 does not show any insider buying or selling transactions. It categorizes the entries as holdings, with buyCount and sellCount both at zero, indicating the filing is a disclosure of existing option-based positions rather than new trades.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Varela Lorenzo Romualdo Mariano

(Last) (First) (Middle)

LUIS BOLINCHES

18

(Street)

VALENCIA VALENCIA 46023

(City) (State) (Zip)

SPAIN

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
02/06/2026

3. Issuer Name and Ticker or Trading Symbol
Moolec Science SA [ MLEC ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Ordinary shares	02/06/2026	06/30/2031	Share Option	934	$7.14	D
Ordinary shares	06/30/2027	06/30/2032	Share Option	933	$7.14	D
Ordinary shares	06/30/2028	06/30/2033	Share Option	933	$7.14	D

Explanation of Responses:

	/s/ Romualdo Mariano Varela Lorenzo	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)